Thursday, July 5, 2018

Clinical Evidence | Forever Young BBL™ | Sciton



Groundbreaking study from Stanford University about Forever Young BBL

*BBL is FDA cleared for, but not limited to, benign pigmented lesions, cutaneous lesions, cutaneous vascular lesions, hair reduction, and pustular inflammatory acne vulgaris. BBL is not FDA cleared for changing gene expression or anti-aging.

No comments:

Post a Comment